In Memoriam

In memoriam: John S. Blanchard

Nuala Del Piccolo
Jan. 17, 2022

John S. Blanchard, an enzymologist committed to finding treatments for antibiotic-resistant bacterial infections, died Nov. 5. He was 67.

Blanchard was born to Nathaniel and Constance (née Greene) Blanchard on Feb. 20, 1954. He grew up in Connecticut and enjoyed playing sports, including swimming, tennis, golf and hockey.

John S. Blanchard

He earned his bachelor’s degree from Lake Forest College in 1975 and his Ph.D. in biochemistry from the University of Wisconsin–Madison in 1978. Blanchard subsequently performed research, taught courses, and mentored students at Albert Einstein College of Medicine for 42 years, first as a postdoctoral fellow and later as a member of the faculty.

Blanchard’s research focused on characterizing enzymes’ mechanisms of action through a combination of structural, kinetic and chemical analyses. In the early portion of his career, Blanchard studied enzymes involved in biosynthesis and metabolism. Later, he turned his attention to enzymes found in bacterial pathogens such as tuberculosis.

In a particularly impactful 2009 Science paper, Blanchard demonstrated how the tuberculosis enzyme β-lactamase contributes to drug resistance and how a two-drug combination can circumvent this resistance. The treatment course later proved effective in preliminary studies in humans.

In a memorial posted to Einstein’s website, Executive Dean Edward R. Burns reflected on the aftermath of Blanchard’s 2009 report. “At John’s request, Einstein elected not to patent his discovery because he didn’t want to impede its use in Africa, where both multidrug resistant and (extensively drug-resistant tuberculosis) remain serious health risks. He was a pioneering enzymologist with a huge heart.”

Over the course of his career, Blanchard published almost 200 peer-reviewed articles and received six full and four provisional patents. He was also a dedicated supporter of young scientists: He encouraged undergraduates to join his lab; served as adviser to Einstein’s Student Journal Club and Summer Undergraduate Research Program; and advocated for retirement benefits on behalf of young faculty.

In recognition of his accomplishments inside and outside the lab, Blanchard received the American Chemical Society Texas A&M University Section’s A.I. Scott Medal for Excellence in Biological Chemical Research in 2014 and Einstein’s Marshall S. Horwitz Faculty Prize for Research Excellence in 2017. Blanchard donated his prize money for the latter award to Einstein’s Graduate Programs in the Biomedical Sciences.

Blanchard is survived by his wife, Kim; children, Ginny and Charles; and brother Scott.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nuala Del Piccolo

Nuala Del Piccolo is a scientific writer at Imperial College London. She earned her B.S. in biomedical engineering and Ph.D. in materials science at Johns Hopkins University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Alrubaye wins research and teaching awards
Member News

Alrubaye wins research and teaching awards

Dec. 8, 2025

He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
Member News

Jordahl named Gilliam Fellow

Dec. 1, 2025

He will receive three years of funding to support his thesis research.

Bibel named assistant professor
Member News

Bibel named assistant professor

Nov. 24, 2025

She began her position at Loyola Marymount University in August 2025.

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

Cotruvo named Blavatnik award finalist
Member News

Cotruvo named Blavatnik award finalist

Nov. 17, 2025

He received a $15,000 prize and was honored at a gala in October.